Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Vijaya Diagnostic
Join Channel
Consolidated Standalone

Vijaya Diagnostic

₹1011.3 -6.4 | 0.6%

Market Cap ₹10388 Cr.

Stock P/E 72.2

P/B 12

Current Price ₹1011.3

Book Value ₹ 84.2

Face Value 1

52W High ₹1276.8

Dividend Yield 0.2%

52W Low ₹ 800

Edit Ratio

Vijaya Diagnostic Research see more...

Overview Inc. Year: 2002Industry: Hospital & Healthcare Services

Vijaya Diagnostic Centre Ltd offers diagnostic services for patients in India. It provides laboratory offerings, including medical biochemistry, haematology and immune-haematology, medical pathology, histopathology and cytopathology, microbiology, serology, cytogenetics, and molecular pathology; radiology and imaging services comprising magnetic resonance imaging, multi slice CT, CBCT (three-D dental), mammography, DEXA/bone densitometry, ultrasound/colour doppler, nuclear medicinal drug and PET/CT, and digital X-ray; and cardiology, neurology, and gastroenterology services. The employer additionally provides fitness checkups and home sample collection services. It has a network of 11 reference laboratories and 80 diagnostic centre across 13 cities and towns inside the states of Telangana and Andhra Pradesh, and in the National Capital Region and Kolkata. The corporation was founded in 1981 and is based totally in Hyderabad, India.

Read More..

Vijaya Diagnostic Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Vijaya Diagnostic Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Net Sales 121 139 133 155 156 183 169 173 188 202
Other Income 6 7 5 3 4 5 5 6 7 6
Total Income 127 146 138 158 160 187 174 179 195 208
Total Expenditure 73 81 80 92 95 107 102 104 115 120
Operating Profit 54 64 57 66 65 80 72 74 81 88
Interest 6 6 6 6 6 6 7 7 7 8
Depreciation 12 14 15 16 17 17 18 19 21 22
Exceptional Income / Expenses 0 0 -2 0 0 0 0 -1 0 0
Profit Before Tax 35 45 35 44 42 57 47 47 52 58
Provision for Tax 9 11 9 10 10 15 11 13 14 15
Profit After Tax 26 34 26 34 32 42 35 35 39 43
Adjustments -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Profit After Adjustments 26 33 26 33 31 42 35 35 38 43
Adjusted Earnings Per Share 2.6 3.3 2.5 3.3 3.1 4.1 3.4 3.4 3.7 4.2

Vijaya Diagnostic Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 293 339 377 462 459 548 681 732
Other Income 10 15 12 13 14 24 18 24
Total Income 303 354 389 475 473 572 700 756
Total Expenditure 184 206 211 259 277 330 408 441
Operating Profit 118 148 178 217 196 242 292 315
Interest 14 15 15 16 21 24 27 29
Depreciation 40 49 50 53 62 57 71 80
Exceptional Income / Expenses 0 0 0 0 0 -2 -1 -1
Profit Before Tax 65 83 112 147 114 159 193 204
Provision for Tax 19 21 27 37 28 39 49 53
Profit After Tax 46 63 85 111 85 120 144 152
Adjustments -0 0 -1 -1 -1 -1 -1 0
Profit After Adjustments 46 63 84 110 85 119 143 151
Adjusted Earnings Per Share 4.5 6.1 8.3 10.8 8.3 11.6 13.9 14.7

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 24% 14% 15% 0%
Operating Profit CAGR 21% 10% 15% 0%
PAT CAGR 20% 9% 18% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -6% 30% NA% NA%
ROE Average 20% 19% 22% 23%
ROCE Average 30% 29% 33% 33%

Vijaya Diagnostic Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 207 275 359 468 545 657 796
Minority's Interest -0 -0 0 1 2 3 3
Borrowings 32 22 3 0 0 0 0
Other Non-Current Liabilities 110 126 128 169 232 247 312
Total Current Liabilities 57 59 44 66 66 73 163
Total Liabilities 405 481 535 705 845 980 1274
Fixed Assets 259 272 268 370 524 742 865
Other Non-Current Assets 9 23 28 64 46 26 102
Total Current Assets 137 186 239 270 276 211 307
Total Assets 405 481 535 705 845 980 1274

Vijaya Diagnostic Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 16 10 56 7 11 24 22
Cash Flow from Operating Activities 91 106 130 158 165 183 224
Cash Flow from Investing Activities -90 -31 -130 -123 -110 -142 -182
Cash Flow from Financing Activities -7 -30 -49 -31 -42 -45 -52
Net Cash Inflow / Outflow -6 46 -49 4 13 -4 -9
Closing Cash & Cash Equivalent 10 56 7 11 24 22 13

Vijaya Diagnostic Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 4.5 6.13 8.28 10.76 8.29 11.61 13.94
CEPS(Rs) 8.43 10.95 13.3 16.02 14.39 17.26 20.89
DPS(Rs) 0 0 0 1 1 1 2
Book NAV/Share(Rs) 20.11 26.92 35.13 45.73 53.18 64.09 77.32
Core EBITDA Margin(%) 36.95 39.14 44.05 44.05 39.64 39.74 40.1
EBIT Margin(%) 26.95 29.16 33.81 35.43 29.28 33.35 32.27
Pre Tax Margin(%) 22.32 24.62 29.76 31.88 24.72 28.97 28.35
PAT Margin (%) 15.81 18.45 22.6 23.93 18.55 21.84 21.1
Cash Profit Margin (%) 29.36 32.96 35.99 35.33 31.99 32.24 31.46
ROA(%) 11.42 14.11 16.76 17.85 11 13.11 12.76
ROE(%) 22.58 26.07 26.91 26.85 16.89 19.96 19.84
ROCE(%) 31.56 35.47 37.97 39.37 26.53 30.4 30.27
Receivable days 11.38 9.22 7.12 6.5 7.65 8.57 8.3
Inventory Days 2.72 2.67 2.62 2.73 2.51 2.41 2.71
Payable days 196.16 180.59 140.18 111.8 152.97 169.19 142.28
PER(x) 0 0 0 40.7 47.18 54.69 72.22
Price/Book(x) 0 0 0 9.57 7.36 9.91 13.02
Dividend Yield(%) 0 0 0 0.23 0.26 0.16 0.2
EV/Net Sales(x) -0.01 -0.24 -0.49 9.24 8.44 11.73 15.09
EV/Core EBITDA(x) -0.03 -0.55 -1.04 19.73 19.76 26.58 35.28
Net Sales Growth(%) 0 15.8 11.19 22.73 -0.68 19.29 24.39
EBIT Growth(%) 0 25.31 28.9 28.63 -17.93 35.86 20.39
PAT Growth(%) 0 35.09 36.19 30 -23.01 40.41 20.19
EPS Growth(%) 0 36.23 35.09 29.84 -22.92 40.03 20.07
Debt/Equity(x) 0.2 0.12 0.01 0 0 0 0
Current Ratio(x) 2.41 3.18 5.4 4.08 4.17 2.9 1.89
Quick Ratio(x) 2.37 3.13 5.34 4.02 4.14 2.83 1.86
Interest Cover(x) 5.83 6.42 8.35 9.96 6.42 7.61 8.22
Total Debt/Mcap(x) 0 0 0 0 0 0 0

Vijaya Diagnostic Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 54.98 54.9 54.87 54.06 53.93 53.91 53.91 53.05 52.63 52.6
FII 20.27 20.68 19.95 20.09 20.08 18.14 17.54 19.36 19.56 18.27
DII 19.03 18.64 19.82 20.8 21.49 23.46 24.63 23.72 24.07 25.34
Public 5.72 5.78 5.36 5.05 4.5 4.49 3.92 3.87 3.74 3.79
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 169.19 to 142.28days.
  • Company is almost debt free.

Cons

  • Stock is trading at 12 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Vijaya Diagnostic News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!